STRM – Sell Recommendation
STRM – Streamline Health Solutions (Nasdaq) (Closing Price – $3.50)
Streamline Health reported second quarter results today and once again released disappointing results.
Streamline Health reported revenue of 3.2 million which was down from 4.58 million reported in the comparable quarter last year. They also posted a loss of 12 cents a share compared to a profit of two cents last year.
Due to the continued poor results and the inability of Streamline Health to finalize its already delayed contracts I am going to give a sell recommendation. I am going to book a loss at today’s closing price.
Disclosure: I have no position in STRM.
If you liked this article, you might want to sign up for my FULL RSS FEEDS. Then, you will get my daily posts in your email and can read them at any time. To subscribe CLICK HERE
